Filing Details
- Accession Number:
- 0001209191-20-010482
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-19 16:05:59
- Reporting Period:
- 2020-02-14
- Accepted Time:
- 2020-02-19 16:05:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1438533 | Retrophin Inc. | RTRX | Pharmaceutical Preparations (2834) | 262383102 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1698262 | E. William Rote | C/O Retrophin, Inc. 3721 Valley Centre Drive, Ste 200 San Diego CA 92130 | Senior Vice President, R&D | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-02-14 | 1,250 | $16.72 | 26,896 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-18 | 1,250 | $16.55 | 25,646 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were made pursuant to a written plan meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares to cover the tax obligation that occurred upon the vesting of restricted stock units.
- Includes an aggregate of 961 shares of the Issuer's common stock acquired by the reporting person on May 30, 2019 and November 30, 2019 pursuant to an employee stock purchase program.
Billionaire Hedge Funds
